FDA Approved: GRALISE — Original Application (Almatica Pharma LLC)

View source ↗

Summary

FDA granted approval for GRALISE (gabapentin) under the original NDA from Almatica Pharma LLC for the treatment of postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• GRALISE (gabapentin)

Snippet

ORIG AP for GRALISE (GABAPENTIN)